Related Experiment Video

Updated: Jun 14, 2026

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori
10:30

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori

Published on: November 12, 2015

36.1K

The future of colorectal cancer research: an interview with Hans Schmoll

Hans-Joachim Schmoll1,2

  • 1Clinic of Internal medicine IV, Department Internal Medicine, University Clinic Halle, Martin-Luther University, Halle, Germany.

Future Oncology (London, England)
|October 19, 2020
PubMed

Insights

Dr. Hans Schmoll is a leading medical oncologist in Germany, significantly influencing cancer treatment standards and education. His research established global benchmarks for genitourinary, gastrointestinal, and colon cancer management.

Area of Science:

  • Medical Oncology
  • Cancer Research

Background:

  • Dr. Hans Schmoll has had a distinguished career spanning over four decades in medical oncology.
  • He is recognized as a highly influential figure in Germany and German-speaking countries.

Discussion:

  • Dr. Schmoll's editorial work on a comprehensive German reference book has shaped medical and multidisciplinary oncology standards and education.
  • His research has significantly advanced the understanding and treatment of genitourinary and gastrointestinal cancers.

Key Insights:

  • He established worldwide standards for managing germ-cell cancer.
  • His contributions include defining standards for early and late stages of colon cancer treatment.

Outlook:

  • Dr. Schmoll's leadership roles in the European Society of Medical Oncology, including chairing the Multidisciplinary Oncology Committee and the 2006 Istanbul Congress, highlight his impact on international oncology.
  • His work continues to influence cancer care and research globally.

Keywords:
clinical trial designclinical trialscolorectal cancerpatient engagementpersonalized medicinepreventionscreeningtreatment

More Related Videos

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

19.8K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.4K

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...